Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sonexa Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00842673
First received: February 10, 2009
Last updated: June 5, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)